+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth



P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth



Journal of Clinical Periodontology 31(9): 758-763



To determine whether there is association between genotypes of drug transporter multidrug resistant (MDR)1 gene coding drug transporter P-glycoprotein and gingival overgrowth in kidney transplant patients. Fifty-four unrelated kidney transplant patients suffering from gingival overgrowth as well 120 control transplant patients without overgrowth were enrolled into the study. Gingival overgrowth was assessed by two independent periodontal specialists at 6 months after transplantation. During the post-transplant period all patients were given medication, which included cyclosporine A, diltiazem or verapamil, prednisone, azathioprine. MDR1 C3435T polymorphism was determined using the polymerase chain reaction-restriction fragment length polymorphism assay. In kidney transplant patients suffering from gingival overgrowth mean score of gingival overgrowth was 1.43 +/- 0.63, whereas in control subjects was 0.0. Patients with gingival overgrowth induced by immunosuppressive medication were characterized by similar distribution of MDR1 genotypes. There were no significant differences of 3435CC, 20.4% and 22.5%, 3435CT, 61.1% and 54.2% and 3435TT, 18.5% and 23.3% genotypes (frequencies) between patients with and without gingival overgrowth. The risk of gingival overgrowth was the highest among patients carrying 3435CT genotype (OD 1.33), but did not differ markedly from the other genotypes, i.e. 3435CC (OD 0.88) and 3435TT (OD 0.75). Likewise to genotypes, distribution of alleles was similar in patients with gingival overgrowth and healthy gingiva. The wild-type allele 3435C was found in 50.9% and 49.6% of subjects whereas the mutated allele 3435T was revealed in 49.1% and 50.4% of patients with and without gingival overgrowth, respectively. The evaluated risk of gingival overgrowth in patients with 3435C allele was 1.06 versus 0.95 in those with healthy gingiva. The medication regimen administered in both groups of the study was comparable. Immunohistochemical studies revealed expression of P-glycoprotein in ducts of the salivary gland. No association between the MDR1 gene polymorphism and gingival overgrowth was revealed in kidney transplant patients administered cyclosporine A as a principal immunosuppressive agent. Further studies are needed to elucidate the role of P-glycoprotein in drug transport in salivary glands.

(PDF emailed within 0-6 h: $19.90)

Accession: 049839855

Download citation: RISBibTeXText

PMID: 15312098

DOI: 10.1111/j.1600-051x.2004.00554.x


Related references

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population. Pharmacological Reports 59(2): 199-205, 2007

TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth. Oral Diseases 17(4): 414-419, 2011

SPARC gene polymorphism in renal transplant patients with gingival overgrowth. Journal of Periodontology 78(11): 2185-2189, 2007

Interleukin-6 gene polymorphism in renal transplant patients with and without gingival overgrowth. Journal of Clinical Periodontology 32(9): 955-958, 2005

Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. Archives of Oral Biology 59(3): 283-288, 2014

Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth. Journal of Periodontal Research 45(1): 143-147, 2010

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. European Journal of Clinical Pharmacology 61(5-6): 389-394, 2005

Role of MDR1 gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients. Journal of Periodontal Research 43(6): 665-672, 2008

The role of MDR1 C3435T gene polymorphism on gingival hyperplasia in Turkish renal transplant patients treated with cyclosporine in the absence of calcium channel blockers. Transplantation Proceedings 45(6): 2233-2237, 2014

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics 13(5): 259-263, 2003

Pre-transplant gingival hyperplasia predicts severe cyclosporin-induced gingival overgrowth in renal transplant patients. Journal of Clinical Periodontology 25(3): 225-230, 1998

Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. Journal of Periodontal Research 38(2): 141-146, April, 2003

The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. Journal of Periodontology 77(5): 865-873, 2006

The interleukin-10 gene promoter polymorphisms are associated with cyclosporin A-induced gingival overgrowth in renal transplant patients. 2013

Interleukin-10 gene promoter polymorphisms are associated with cyclosporin A-induced gingival overgrowth in renal transplant patients. Archives of Oral Biology 58(9): 1199-1207, 2014